Aethlon Medical Inc (AEMD)

[philife]

To answer your first question. ESI has a distinct advantage over current assays because current assays use antibodies to bind to cells. These various antibodies have to be licensed from the entity who patented it. This can be very costly (This is one of the major reasons DR.T joined up with Aethlon. We have patents on lectin approach.). With the lectin approach ESI will be able to essentially get a sample of every exosome that is floating in your system and differentiate between them instantly. Thus allowing ESI to more efficiently identify potential conditions. Another advantage is often the main tumor is different from metastatic tumors. Thus the same drug that works on the main tumor might not work on the metastatic tumor. ESI will be able to tell if the your tumors are different. This is what I understood from the presentations and is not fact, but just my understanding.

I think we are doing HIV because we can provide earlier diagnosis. As soon as a cell is altered by an HIV infection; this cells exosomes change too. This change occurs because they have discovered that exosomes are mirror copies of the host cell that they came from. Thus, technically as soon as you become infected and the infected cell produces exosomes, ESI's assay can tell. Normally, tests can diagnose after at least two weeks and sometimes it can take up to 6 months. This time difference can be a major advantage. I recall a baby that was born and contracted HIV from the mother. The doctor started an extreme regimen of anti-viral drugs right after birth and the infection never developed hideouts and never progressed and was "cured". I think they use the term "cured" liberally in this article, but take it for what you will. Again, This is what I understood from talks with researchers at ESI and is not fact, but just my understanding.

http://www.huffingtonpost.com/2013/03/03/baby-cured-of-hiv_n_2803041.html